Cannabis

Vitura Health (ASX:VIT) and ASX 300 Cannabis Marketplace Expansion

June 12, 2026 11:35 AM AEST| By Sam

Vitura Health's marketplace model highlights the growing importance of distribution, healthcare access and pharmacy connectivity within Australia's evolving medicinal cannabis sector.

ASX Cannabis Stocks 2026: Why Cash Runway Is Driving The Reset

June 11, 2026 04:52 PM AEST| By Sam

ASX cannabis stocks are being reassessed through cash runway, cash flow and operational discipline, with investors focusing on which companies can turn sector growth into sustainable financial progress.

ASX Cannabis Stocks and the Export Discipline Story in 2026

June 11, 2026 04:40 PM AEST| By Sam

# Why Export Discipline Is Becoming the Real Test for ASX Cannabis Stocks ### Highlights * Export quality, cash discipline and operational execution are becoming the key measures used to assess cannabis businesses across the Australian market.

ASX Cannabis Stocks 2026: Why Proof Matters More Than Hype

June 11, 2026 04:17 PM AEST| By Sam

Cannabis stocks are entering a more evidence-driven phase as readers focus on revenue quality, operational discipline and regulatory execution, with leading ASX names facing growing pressure to convert sector opportunity into measurable business resu...

ASX Cannabis Stocks ASX 300 And Prescription Momentum

June 11, 2026 03:27 PM AEST| By Sam

ASX cannabis stocks are being viewed through prescription activity, patient access, operational delivery and healthcare participation across leading medicinal cannabis companies.

Cannabis Stocks Across ASX 300 Drawing Sector Attention

June 11, 2026 03:27 PM AEST| By Sam

Five ASX-listed cannabis companies remain active across medicinal cannabis, healthcare products, cultivation, and wellness markets, highlighting ongoing sector development and commercial activity.

Can ASX Cannabis Names Stand Apart From North America?

June 11, 2026 03:27 PM AEST| By Sam

ASX cannabis stocks and North American operators differ through regulation, market size, funding access and commercial pathways, making operational proof central to the sector debate.

ASX Cannabis Stocks Outlook Beyond 2026: Growth, Reform and Exports

June 10, 2026 03:23 PM AEST| By Sam

Australia's medicinal cannabis sector is entering a new phase driven by exports, regulatory developments, consolidation and wider acceptance. These trends are expected to influence industry growth, competition and market positioning in the years ahea...

ASX Cannabis Stocks Risk vs Reward: What Matters in 2026

June 10, 2026 03:21 PM AEST| By Sam

Australia's cannabis sector continues to offer growth exposure, but profitability challenges, funding needs and shareholder dilution remain major considerations. Businesses with disciplined capital management and sustainable operations may be better...

Prescription for Growth: How Australia's Cannabis Market Is Maturing

June 10, 2026 02:54 PM AEST| By Sam

Australia’s medicinal cannabis industry is evolving into a mature healthcare market driven by patient demand, regulatory oversight, industry consolidation and growing export opportunities, with companies focusing increasingly on commercial execution...

Export Discipline Meets Cannabis Stocks All Ordinaries

June 10, 2026 11:17 AM AEST| By Sam

Cannabis stocks are drawing renewed attention as export discipline, operational efficiency, prescription pathways and cash management become central themes across the Australian medicinal cannabis sector.

ASX Cannabis Stocks and ASX 300 Revenue Pathways Reshaping Sector Focus

June 10, 2026 11:17 AM AEST| By Sam

ASX cannabis stocks are increasingly assessed through operational execution, cultivation efficiency, prescription access, manufacturing capability and compliance frameworks as the medicinal cannabis sector continues to evolve.

Why Are Cannabis Stocks Facing A Fresh Market Reset?

June 10, 2026 11:17 AM AEST| By Sam

Medicinal cannabis stocks are being viewed through cash runway, operational discipline, manufacturing capability and prescription access as the sector moves toward a more evidence-focused phase.

ASX Cannabis Stocks Eye a Bigger Prize Beyond Australia

June 09, 2026 03:11 PM AEST| By Sam

Australian medicinal cannabis companies are increasingly targeting overseas markets, particularly Europe, to access larger demand pools. While export growth offers broader opportunities, regulatory complexity and global competition remain important c...

The Cannabis Boom Few Saw Coming: Which ASX Stocks Are in the Spotlight?

June 09, 2026 03:09 PM AEST| By Sam

Australia's medicinal cannabis market continues expanding through stronger patient demand, growing clinical acceptance and tighter regulation, while listed cannabis companies navigate competition, funding pressures and evolving healthcare opportuniti...

Australia's Cannabis Stock Boom Hides a High-Stakes Market Twist

June 09, 2026 03:08 PM AEST| By Sam

Australia's medicinal cannabis sector is expanding rapidly, supported by growing demand and medical acceptance. Listed cannabis companies are pursuing diverse strategies, but regulation, competition and volatility continue to shape this evolving mark...